StockData
Electra Therapeutics, Inc. logo

Electra Therapeutics, Inc. (ETRA) stock

ETRANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$8.94+0.51 (+6.05%)

Close on Nov 19, 2026Market cap $562.03MP/E –Yield –

Electra Therapeutics net income

Net income is the profit left for shareholders after every expense, interest and tax.

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$23.93M–
Q2 FY2026Jun 30, 2026-$26.75M–
Q1 FY2026Mar 31, 2026-$22.17M–
Q3 FY2025Sep 30, 2025-$18.09M–
Q2 FY2025Jun 30, 2025-$17.58M–
Q1 FY2025Mar 31, 2025-$7.79M–

More Electra Therapeutics figures

See a number that looks wrong?